Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains
- 3 March 2010
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 42 (6-7) , 506-509
Abstract
Candida species are a common cause of bloodstream infection among hospitalized patients. Increasingly these infections are caused by strains resistant to commonly used antifungal agents. The aim of this study was to assess the association between exposure to specific antimicrobial agents and subsequent bloodstream infection with fluconazole-non-susceptible and fluconazole-susceptible Candida strains. A retrospective case-case-control study was performed. From 2002 to 2006, 50 consecutive patients with hospital-acquired bloodstream infection caused by Candida strains not fully susceptible to fluconazole were identified (case group 1). For comparison, 54 patients with fluconazole-susceptible candidaemia (case group 2) and a control group of 104 patients without candidaemia were studied. Models were adjusted for demographic and clinical risk factors. The risk for candidaemia associated with exposure to specific antimicrobial agents was assessed. Piperacillin/tazobactam (odds ratio (OR) 6.8, 95% confidence interval (CI) 1.4–32.2) and ciprofloxacin (OR 8.0, 95% CI 1.5–42.5), but not fluconazole, were significant risk factors for bloodstream infection with fluconazole-non-susceptible Candida. Only ciprofloxacin (OR 7.8, 95% CI 1.2–50.7) was associated with bloodstream infection with fluconazole-susceptible Candida. Despite adjustment for prior exposure to fluconazole, exposure to specific antibacterial agents was associated with hospital-acquired bloodstream infection with fluconazole-non-susceptible Candida.Keywords
This publication has 11 references indexed in Scilit:
- Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream InfectionsArchives of internal medicine (1960), 2009
- Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility TestingClinical Microbiology Reviews, 2006
- Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control StudyAntimicrobial Agents and Chemotherapy, 2005
- Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization by Candida glabrata in Adult MiceAntimicrobial Agents and Chemotherapy, 2005
- Reference Group Choice and Antibiotic Resistance OutcomesEmerging Infectious Diseases, 2004
- Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant EnterococcusEmerging Infectious Diseases, 2002
- Increase in prevalence of nosocomial non- Candida albicans candidaemia and the association of Candida krusei with fluconazole useJournal of Hospital Infection, 2002
- Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humansAntimicrobial Agents and Chemotherapy, 1993
- Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgeryAntimicrobial Agents and Chemotherapy, 1990
- A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microfloraInfection, 1988